UBS AM’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28M | Buy |
85,702
+33,564
| +64% | +$502K | ﹤0.01% | 2322 |
|
|
2025
Q1 | $841K | Buy |
52,138
+3,157
| +6% | +$50.9K | ﹤0.01% | 2375 |
|
|
2024
Q4 | $1.14M | Buy |
48,981
+22,540
| +85% | +$525K | ﹤0.01% | 2308 |
|
|
2024
Q3 | $778K | Sell |
26,441
-3,680
| -12% | -$108K | ﹤0.01% | 2498 |
|
|
2024
Q2 | $708K | Buy |
+30,121
| New | +$708K | ﹤0.01% | 2525 |
|